Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Florine Obrist, Gwenola Manic, Guido Kroemer, Ilio Vitale & Lorenzo Galluzzi. (2015) Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology 2:2.
Read now
Read now
Articles from other publishers (4)
Alfeu Zanotto-Filho, Elizandra Braganhol, Ana Maria Oliveira Battastini & José Cláudio Fonseca Moreira. (2012) Proteasome inhibitor MG132 induces selective apoptosis in glioblastoma cells through inhibition of PI3K/Akt and NFkappaB pathways, mitochondrial dysfunction, and activation of p38-JNK1/2 signaling. Investigational New Drugs 30:6, pages 2252-2262.
Crossref
Crossref
Reem Smoum, Abraham Rubinstein, Valery M. Dembitsky & Morris Srebnik. (2012) Boron Containing Compounds as Protease Inhibitors. Chemical Reviews 112:7, pages 4156-4220.
Crossref
Crossref
Sunil L Harer, Manish S Bhatia & Neela M Bhatia. (2012) Proteasome inhibitors mechanism; source for design of newer therapeutic agents. The Journal of Antibiotics 65:6, pages 279-288.
Crossref
Crossref
Lisa Dalla Via, Chiara Nardon & Dolores Fregona. (2012) Targeting the ubiquitin–proteasome pathway with inorganic compounds to fight cancer: a challenge for the future. Future Medicinal Chemistry 4:4, pages 525-543.
Crossref
Crossref